Replies to post #813893 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

Thanks for your effort bringing this update. Yes indeed it is a very good news for NWBO.

[manibiotech]

" Did they mean that the CVLP had been expanded to include cancer immunotherapies and cancer vaccines or other personalised immunotherapy all of which that specifically and only require molecular profiling or genetic sequencing as part of the treatment process, or, did they mean that the CVLP had been expanded to include: i) cancer immunotherapies 
ii) cancer vaccines 
iii) other personalised immunotherapy that require molecular profiling or genetic sequencing"

[manibiotech]

“ Did they mean that the CVLP had been expanded to include cancer immunotherapies and cancer vaccines or other personalised immunotherapy all of which that specifically and only require molecular profiling or genetic sequencing as part of the treatment process, or, did they mean that the CVLP had been expanded to include:
i) cancer immunotherapies
ii) cancer vaccines
iii) other personalised immunotherapy that require molecular profiling or genetic sequencing”

To me it seems to mean former because they used the word “require” implying that it is referring to multiple things . If “molecular profiling and genetic sequencing” part only referred to ‘other personalized immunotherapy ‘ , then they would have used “requires” in that sentence . Just my take.

[ATLnsider]

Thanks for sharing this news Baxers‼️

[Chiugray]

Baxers, That is great to hear. There are so many projects the UK is taking a lead on.

My thoughts. The Cancer Vaccine Launch Pad (CVLP) can be the engine in the future to match whole genome sequencing (WGS) data to cancer patients for personalized therapies, especially like DCVax-L.

Last year, it was published that Prof. Ashkan sequenced the whole genome for 400 brain tumors. That data set is part of the UK’s 100,000 Genomes Project, and that is the database from which the CVLP will use.

https://www.kch.nhs.uk/news/landmark-uk-study-could-lead-to-more-effective-treatments-for-people-living-with-brain-cancer/

[flipper44]

“Autologous whole-tumour lysate dendritic cell vaccines would fall under the remit of the NHSE Cancer Vaccine
Launch Pad.” — NHS, February 9, 2026

Baxers, thank you for your DD.

[MarauderWarlock33]

This is water tight confirmation that Autologous DCVX- L & Direct are included in the CVLP - No doubt about it. Thank you for your effort in bring this vital information to the board Tommy!